Shell Company. The Company is not, and has never been, an issuer identified in Rule 144(i)(1) promulgated under the Securities Act.
Appears in 7 contracts
Samples: Common Stock Purchase Agreement (Eiger BioPharmaceuticals, Inc.), Convertible Notes Purchase Agreement (Uber Technologies, Inc), Convertible Notes Purchase Agreement (Uber Technologies, Inc)
Shell Company. The Company is not an “ineligible issuer” (as defined in Rule 405 promulgated under the Securities Act) and is not, and has never been, an issuer identified in in, or subject to, Rule 144(i)(1) promulgated under of the Securities Act.
Appears in 5 contracts
Samples: Securities Purchase Agreement (Eloxx Pharmaceuticals, Inc.), Securities Purchase Agreement (Heron Therapeutics, Inc. /De/), Securities Purchase Agreement (Sonendo, Inc.)
Shell Company. The Company is not, and has never beennot been at any time previously, an issuer identified described in Rule 144(i)(1144(i)(1)(i) promulgated under the Securities Act.
Appears in 5 contracts
Samples: Stock Purchase Agreement (Acre Realty Investors Inc), Stock Purchase Agreement (Roberts Realty Investors Inc), Securities Purchase Agreement (DHT Holdings, Inc.)
Shell Company. The Company is not, and has never been, an issuer identified in Rule 144(i)(1) promulgated under the Securities Act.
Appears in 3 contracts
Samples: Common Stock Purchase Agreement (Eiger BioPharmaceuticals, Inc.), Series E Preferred Stock Purchase Agreement (Aduro Biotech, Inc.), Common Stock Purchase Agreement (Aduro Biotech, Inc.)
Shell Company. The Company is not, and never has never been, an issuer identified in that meets the description set forth under Rule 144(i)(1) promulgated under the Securities Act144(i)(1)(i).
Appears in 2 contracts
Samples: Preferred Stock Purchase Agreement, Preferred Stock Purchase Agreement (Lexicon Pharmaceuticals, Inc.)
Shell Company. The Company is not, and has never been, an issuer identified described in Rule 144(i)(1144(i) promulgated under the Securities Act.
Appears in 1 contract
Samples: Securities Purchase Agreement (RedHill Biopharma Ltd.)
Shell Company. The Company is not, and nor has never it ever been, an issuer identified in Rule 144(i)(1) promulgated under the Securities Act.
Appears in 1 contract
